Latest Articles
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology
Published: Jan. 22, 2026, 4:02 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - targetedonc.com
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer targetedonc.com
Published: Jan. 22, 2026, 4:02 p.m.
Terumo launches SurTract Safety Syringe in U.S. - Med-Tech Insights
Terumo launches SurTract Safety Syringe in U.S. Med-Tech Insights
Published: Jan. 6, 2026, 4:18 p.m.
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Dec. 22, 2025, 1:15 p.m.
Dow Update: What dividend safety score for REPX stock - 2025 Risk Factors & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Dow Update: What dividend safety score for REPX stock - 2025 Risk Factors & Free Expert Verified Stock Movement Alerts moha.gov.vn
Published: Dec. 21, 2025, 8:03 a.m.
Evaluation of the long-term efficacy and safety of dydrogesterone in the treatment of endometriosis/dysmenorrhea - BMC Women's Health
Evaluation of the long-term efficacy and safety of dydrogesterone in the treatment of endometriosis/dysmenorrhea BMC Women's Health
Published: Nov. 12, 2025, 3:21 p.m.
TGA yet to investigate the safety of most medicinal cannabis products - Australian Broadcasting Corporation
TGA yet to investigate the safety of most medicinal cannabis products Australian Broadcasting Corporation
Published: Sept. 9, 2025, 7:22 p.m.
Can Safety Shot Inc. rally from current levels - July 2025 Earnings & High Win Rate Trade Alerts - Newser
Can Safety Shot Inc. rally from current levels - July 2025 Earnings & High Win Rate Trade Alerts Newser
Published: Aug. 28, 2025, 7:52 p.m.
Myelofibrosis Trials: Diverging Narratives on Enrollment, Endpoint Clarity, and Safety Data - AInvest
Myelofibrosis Trials: Diverging Narratives on Enrollment, Endpoint Clarity, and Safety Data AInvest
Published: Aug. 11, 2025, 3:12 p.m.
From Data to Decisions: ITI Limited to Implement AI-Driven Road Safety Project in Uttar Pradesh, in Partnership with mLogica- Know More - Indian Masterminds
From Data to Decisions: ITI Limited to Implement AI-Driven Road Safety Project in Uttar Pradesh, in Partnership with mLogica- Know More Indian Masterminds
Published: Aug. 5, 2025, 12:40 p.m.
Link copied to clipboard!